ESKALE study, a French real-world study of esketamine nasal spray for patients with treatment-resistant depression

被引：0
|
作者：
Ludovic, S. [1 ]
Codet, M. A. [2 ]
Rotharmel, M. [3 ]
De Maricourt, P. [4 ]
Boursicot, J. [2 ]
Wattinne, E. Gaudre [2 ]
机构：
[1] Univ Auvergne, Dept Psychiat, CHU Clermont Ferrand, Clermont Ferrand, France
[2] Janssen Cilag Med Affairs, Issy Les Moulineaux, France
[3] CH Rouvray, Dept Psychiat, Sotteville Les Rouen, France
[4] CH Ste Anne, Dept Psychiat, Paris, France
来源：
EUROPEAN PSYCHIATRY | 2022年 / 65卷
关键词：
esketamine; Treatment Resistant Depression; retrospective study; Real World Evidence;
D O I：
10.1192/j.eurpsy.2022.693
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP0437
引用
收藏
页码：S270 / S271
页数：2
相关论文
共 50 条
  • [1] Use of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression in Routine Practice: A Real-World French Study
    Samalin, Ludovic
    Mekaoui, Lila
    Rotharmel, Maud
    Sauvaget, Anne
    Wicart, Clotilde
    Dupin, Julien
    Cohignac, Vanessa
    Gaudre-Wattinne, Emeline
    DEPRESSION AND ANXIETY, 2024, 2024
  • [2] ESKALE study, a French real-world study describing TRD patients with Esketamine nasal spray: final analysis
    Samalin, L.
    Mekaoui, L.
    Rotharmel, M.
    de Maricourt, P.
    Codet, M. -A.
    Wattinne, E. Gaudre
    EUROPEAN PSYCHIATRY, 2023, 66 : S90 - S90
  • [3] A Real-World Study on the Use, Effectiveness, and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression: INTEGRATE Study
    Molero, Patricio
    Ibanez, Angela
    de Diego-Adelino, Javier
    Ramos-Quiroga, J. Antoni
    Garcia Dorado, Marta
    Lopez Rengel, Paola M.
    Saiz, Pilar A.
    ADVANCES IN THERAPY, 2025, : 2335 - 2353
  • [4] ESKALE study, a French real-world study describing TRD patients with Esketamine nasal spray: final analysis
    Samalin, L.
    Mekaoui, L.
    Rotharmel, M.
    de Maricourt, P.
    Codet, M. A.
    Wattinne, E. Gaudre
    EUROPEAN PSYCHIATRY, 2023, 66 : S90 - S90
  • [5] Real-world demographic and clinical profiles of patients with treatment-resistant depression initiated on esketamine nasal spray
    Samalin, Ludovic
    Mekaoui, Lila
    De Maricourt, Pierre
    Sauvaget, Anne
    Codet, Marie-Alix
    Gaudre-Wattinne, Emeline
    Wicart, Clotilde
    Rotharmel, Maud
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2024,
  • [6] Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme
    Samalin, Ludovic
    Rotharmel, Maud
    Mekaoui, Lila
    Gaudre-Wattinne, Emeline
    Codet, Marie-Alix
    Bouju, Sophie
    Sauvaget, Anne
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2022, 26 (04) : 352 - 362
  • [7] CHARACTERISTICS OF REAL-WORLD COMMERCIALLY INSURED PATIENTS WITH TREATMENT-RESISTANT DEPRESSION INITIATED ON ESKETAMINE NASAL SPRAY OR CONVENTIONAL THERAPIES
    Karkare, S.
    Zhdanava, M.
    Nash, A.
    Pilon, D.
    Morrison, L.
    Shah, A.
    Lefebvre, P.
    Joshi, K.
    VALUE IN HEALTH, 2021, 24 : S133 - S133
  • [8] Esketamine nasal spray approved for treatment-resistant depression
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (09) : 573 - 573
  • [9] Esketamine Nasal Spray (Spravato) for Treatment-Resistant Depression
    Chaplin, Steve
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1569): : 54 - 56
  • [10] Esketamine Nasal Spray Effective in Treatment-Resistant Depression
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (04): : 296 - 296
12345